Infographic: Pivotal clinical trial costs

(Image: Getty/RamCreativ) (Getty Images/iStockphoto)

Clinical trials that support FDA approvals of new drugs have a median cost of $19m – representing less than one percent of the average drug development cost, which is estimated at between $2 and $3bn.

These numbers according to a team of researchers from Johns Hopkins Bloomberg School of Public Health who conducted an assessment of the costs of pivotal clinical trials.

Read: Clinical trial cost is a fraction of the drug development bill

The results were published this week in JAMA Internal Medicine.